ExeVir Bio
Acronym: ExeVir
General Information
Identification Code: 180203343227-11
Website: [object Object]
Entity Form: Besloten vennootschap
Registration Category: Companies & groups
Registration Date: 6/18/2021
Last Update: 2/21/2024
EP Accredited Number: 0
Mission & Interests
Goals: ExeVir is a clinical-stage company developing novel antibody therapies that help patients ward off infectious diseases. Our focus is on protecting populations unable to benefit from vaccines, such as immunocompromised individuals. The versatile VHH platform enables both prevention and treatment of bacterial and viral threats.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Public health
- Regional policy
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: - EU Strategy on COVID-19 and infectious diseases Therapeutics
- A Pharmaceutical Strategy for Europe
- Horizon Europe
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: Technologiepark-Zwijnaarde 94
Post Code: 9052
City: Ghent
Country: BELGIUM
Phone: [object Object]
EU Office
Address: Technologiepark-Zwijnaarde 94
Post Code: 9052
City: Ghent
Country: BELGIUM
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Membership Information
Members10 Percent: 1
Members25 Percent: 0
Members50 Percent: 0
Members75 Percent: 0
Members: 1
Members F T E: 0.10000000149011612
Info Members: ExeVir has contracted EURALIA to advise us
Structure
Structure Type: Structure
Is Member Of: https://flanders.bio/en/member-directory/exevir-bio
https://medvia.be/about-medvia/members/
Organisation Members: Flanders Bio
MEDVIA